Get started
Author

Qing Chang

Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer
2017 · Pasquale Sansone, Claudia Savini, et al. · Proceedings of the National Academy of Sciences · 728
Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2022 · Rona Yaeger, Riccardo Mezzadra, et al. · Cancer Discovery · 142
PDF
Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis
2009 · Libo Zhao, Xiaomin Wang, et al. · European Journal of Pharmacology · 133
Cooperative CAR targeting to selectively eliminate AML and minimize escape
2023 · Sascha Haubner, Jorge Mansilla-Soto, et al. · Cancer Cell · 121
Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib
2020 · Yuting Sun, Brooke A. Meyers, et al. · Cancer Research · 103
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors
2016 · Sizhi P. Gao, Qing Chang, et al. · Science Signaling · 66
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
2023 · Walid K. Chatila, Henry Walch, et al. · Nature Communications · 59
PDF
A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR -Mutant Lung Adenocarcinomas with Acquired Resistance to Erlotinib
2016 · Helena A. Yu, Leslie Perez, et al. · Journal of Thoracic Oncology · 57
PDF
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
2023 · Isao Miyazaki, Igor Odintsov, et al. · Nature Cancer · 42
PDF
Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
2021 · Kamini Singh, Jianan Lin, et al. · Cancer Research · 39
PDF
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
2019 · Avnish Kapoor, Wantong Yao, et al. · Cell · 38
PDF
Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis
2021 · Shanshan Duan, Loredana Moro, et al. · Cell Reports · 37
Opposing roles of TGFβ and BMP signaling in prostate cancer development
2017 · Xin Lu, Eun-Jung Jin, et al. · Genes & Development · 36
PDF
Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expressionin vitro
2004 · Manoj Kumar, Zheng-Ren Liu, et al. · World Journal of Gastroenterology · 33
PDF
Gastrointestinal stromal tumors (GISTs) arising in uncommon locations: clinicopathologic features and risk assessment of esophageal, colonic, and appendiceal GISTs
2021 · Shaomin Hu, Lindsay Alpert, et al. · Modern Pathology · 30
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
2022 · Wenjing Su, Radha Mukherjee, et al. · Molecular Cell · 23
PDF
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
2025 · Ninghui Mao, Young Sun Lee, et al. · Science Advances · 21
PDF
KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer
2022 · Seo-Hyun Choi, Jin K. Kim, et al. · Molecular Cancer Research · 18
PDF
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer
2025 · Jacob A. Boyer, Ezra Y. Rosen, et al. · Proceedings of the National Academy of Sciences · 11
PDF
Predicting Gemcitabine Delivery by18F-FAC PET in Murine Models of Pancreatic Cancer
2020 · James Russell, Milan Grkovski, et al. · Journal of Nuclear Medicine · 9
PDF
Inhibition of metastatic progression of SSTR2 gene transfection mediated by adenovirus in human pancreatic carcinoma cells
2006 · Feng Yanping, Huang Tao, et al. · Journal of Huazhong University of Science and Technology [Medical Sciences] · 9
Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis
2004 · Ren-Yi Qin, Ru-Liang Fang, et al. · World Journal of Gastroenterology · 9
PDF
Transfection of antisense oligodeoxynucleotide inhibits heparanase gene expression and invasive ability of human pancreatic cancer cellin vitro
2006 · Gao Jun, Su Lin, et al. · Journal of Huazhong University of Science and Technology [Medical Sciences] · 8
Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration
2025 · Sunyana Gadal, Jacob A. Boyer, et al. · Cancer Research · 6
Abstract P233: TAS0953/HM06 is effective in preclinical models of diverse tumor types driven by RET alterations
2021 · Igor Odintsov, Renate I. Kurth, et al. · Molecular Cancer Therapeutics · 5
Works count: 101
Citation count: 1,793
H-index: 18
I10-index: 19
Year
Topic
Type